Please assess the completion status of the following clinical trial:

Trial Title: Patient-controlled Intravenous Analgesia With Remifentanil Infusion for Labour

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent~* Term pregnancy in labour with singleton fetus in cephalic presentation~* Patients requesting systemic analgesia~* Patients with contraindication for regional anesthesia without fetal compromise (coagulopathy, thrombocytopenia, refusal, etc.)~Exclusion Criteria:~* Refusal to sign written informed consent~* Inability to communicate in English~* Opioid dependence or addiction~* Patients on Methadone~* Allergy or hypersensitivity to remifentanil~* Fetal heart rate abnormalities~* Fetal congenital anomalies

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Continuous infusion (Type: ACTIVE_COMPARATOR): Remifentanil administered by continuous IV infusion, with stepwise increase in infusion rates and placebo demand bolus of normal saline.
- Demand Bolus (Type: ACTIVE_COMPARATOR): Demand bolus of remifentanil with stepwise increase in bolus dose and placebo continuous infusion of normal saline.

Based on this trial design, predict the completion outcome and termination type (if applicable).